GTM strategy · Propensity
Why is Propensity growing?
Working document ·
Analysis published: verdict, drivers and playbook with dated sources. I update it when new evidence comes in.
gtm-rx-v1 · Website ↗
Propensity grew on LinkedIn from 29 employees on 2025-01-01 to 40 on 2026-01-01 (+38%), and LinkedIn counts 53 on 2026-11-15, a separate measurement. Documented are a free entry with visible prices, higher price tiers (Essential from 1,000 (09.2025) to 2,000 dollars per month (pricing page 11.2026)) and the Gartner Challenger placement. The CEO names a human validation step before sales as a driver, which is his statement. Revenue, customer count and funding are open.
Headcount: 29 → 40 (+38% / 12M, 2026-01-01)
My verdict
- What works
- Documented are a free entry with open prices, a clearly named product for small growth teams and a dense presence with blogs, comparison pages and analyst placement. Headcount rose 38 percent from January 2025 to January 2026.
- What does not work or is unproven
- The effect of the human validation step is not documented, the figure of about 50 percent has no denominator and comes only from the CEO. Revenue, customer count and funding are also open, and the price rise may have contributed to growth.
- Transferable to
- Transferable for B2B teams with a product that can be set up in an hour and allows a limited free scope. The prerequisite is a sales team that accepts or rejects leads in the CRM and records the reasons.
The growth drivers
Free entry with visible prices
ObservationProduct-led salesThe captures of 2024-12-14 and 2025-09-09 show a free trial with the 100 top accounts per week, no credit card. Today's FAQ names an intent data sample with 100 accounts and a setup in about an hour. «Book demo» sits next to it, the effect on customer count is not documented.
Price tiers moved upward
ObservationProduct-led salesEssential cost 1,000 dollars per month on 2025-09-09, Strategic 2,000. The pricing page of 2026-11-12 shows 2,000, 3,000 and a new Unlimited tier at 4,000 dollars. A dedicated account manager starts at Strategic. More revenue per customer is possible but says nothing about the number of customers.
Analyst and conference presence as proof
Company statementContent-ledAccording to Propensity, Gartner names the company a Challenger in the ABM platform Magic Quadrant for the second time in 2026. Inc. lists it at rank 70 of the Inc. 5000 with 3,911 percent three-year growth, Inc. does not name the years of the three-year window. Blogs on UNBOUND and the Global ABM Conference carry the CEO's five-stage model.
Human validation before handoff
Company statementSales-ledIn November 2026 the CEO says a market research team validates leads by phone and about 50 percent of them go to pipeline. The company blog calls a human validation step an experiment with a hypothesis. The product pages do not mention it and the denominator of the number is missing.
GTM fingerprint
Twelve reviewed ratings from the analysis (0–5), projected language-independently — the same shape in every language, comparable across tools.
- Product-led salesPrimary · Acquisition
Gratis-Einstieg mit 100 Konten und sichtbare Preise, daneben Demo und Account Manager ab Strategic.
- Content-ledSecondary · Awareness
Blogs zu Konferenzen, Vergleichsseiten, Gartner- und Inc.-Platzierung als Beleg, Wirkung nicht gemessen.
- Sales-ledEmerging · Conversion
Menschliche Prüfung von Leads vor dem Vertrieb laut CEO, Betrieb nicht beobachtet.
Evidence table: maturity and strength of evidence per axis
| Axis | Maturity | Evidence | Note |
|---|---|---|---|
| Growth outcomes | 4/5 | 60 % | |
| Inflection timeline | 2/5 | 40 % | |
| Market & ICP | 3/5 | 50 % | |
| Positioning & messaging | 3/5 | 65 % | |
| Product wedge | 3/5 | 55 % | |
| Acquisition & distribution | 3/5 | 45 % | |
| Activation & conversion | 3/5 | 45 % | |
| Monetisation & sales | 3/5 | 60 % | |
| Retention & expansion | 2/5 | 30 % | weak evidence |
| Org & execution | 2/5 | 25 % | weak evidence |
| Growth loops | 1/5 | 20 % | weak evidence |
| Causal synthesis | 2/5 | 30 % | weak evidence |
Maturity from 0 to 5 describes how pronounced and repeatable the observed mechanism is. Evidence from 0 to 100 describes how strong and independent the sources are. Both describe only this measure, not the quality of the company.
How to copy this
The actionable steps behind this growth — each mapped to the open 12-lever framework.
- 1
On Monday compute your lead rate twice: once over passed validations only and once over all validated leads, each against unvalidated leads of the same score tier.
DECODE · Lever 2Effort: low - 2
Build a free entry with a clearly limited scope (for example 100 accounts per week) and show prices openly on the pricing page.
SHAPE · Lever 6Effort: medium - 3
Add a required field «accepted or rejected» with one reason from five options in your sales CRM and review the reasons every month.
EVOLVE · Lever 12Effort: low
Sources
- Inc.: Firmenprofil Propensity, Inc. 5000 2026 · Inc. · 2026-09-16
- G2: Propensity Reviews (33 Bewertungen) · G2 · 2026-11-12
- Gartner Peer Insights: Propensity · Gartner Peer Insights · 2026-10-30
- Propensity: Preisseite (Archiv 09.09.2025) · Wayback Machine, Propensity · 2025-09-09
- Propensity: Preisseite · Propensity · 2026-11-12
- Propensity Named a Challenger in the 2026 Gartner Magic Quadrant · PR Newswire, Propensity · 2026-10-13
- Sumner Vanderhoof im Gespräch: Autonomous ABM Still Needs a Human (Tag 01, nur Monat November 2026 bekannt) · Mighty & True · 2026-11-01
- What's the Only Moat Left for SaaS in the AI Era? mit Sumner Vanderhoof · Cadre AI · 2026-11-12
- Propensity Review 2026 (Wettbewerber) · ZoomInfo Pipeline · 2026-11-13
Method: evidence-based GTM analysis (GTM-RX)
We reconstruct the go-to-market strategy from dated, publicly available sources. Observable facts, statements by the company and our assessments are labelled separately. Every key statement points to its source and the period it covers. Contradictions and missing data stay visible.
Team growth, job postings, pricing and product changes are signals. They prove neither revenue growth nor that a particular GTM measure succeeded. We judge transferability to other companies by target customers, business model, sales motion and available resources.
In addition, we look at the organisational prerequisites for AI through a TOE / dynamic capabilities lens from the AI Monitor research. This lens does not replace a company survey. Capabilities that cannot be evidenced publicly are rated as unknown. GTM-RX is not a scientific impact study and not a recommendation for a particular tool.
How statements are labelled
- Observation
- Directly measured or documented, with source and date.
- Company statement
- Statement by the company, not independently verified.
- Assessment
- Our assessment: timing, mechanism and evidence support the conclusion.
- Hypothesis
- Open explanation: coincided in time, cause not evidenced.
Analysis of 15 November 2026 · Sources as of 13 November 2026 · Version gtm-rx-v1 · 9 sources checked
Team trend and turning points
Headcount growth
Based on LinkedIn data.
- 2024-04-08
CEO beschreibt ABM für kleinere Wachstumsteams
Frühe Zielgruppe: kleine Wachstumsteams (Folgenbeschreibung).
- 2024-12-14
Preisstand: Free Trial, Essential 1'000, Strategic 2'000 Dollar
Basis für den Preisvergleich.
- 2026-01-01
40 Mitarbeitende, +37.9 % in zwölf Monaten
Jüngster Punkt der echten Reihe, Basis von g12 und g24.
- 2026-01-11
Startseite: «Only ABM Platform that Delivers Contact-Level Attribution»
Positionierung vor dem Wechsel zu «AI-powered GTM».
- 2026-09-16
Inc. 5000 Rang 70 mit 3'911 % Dreijahreswachstum
Umsatzsignal auf Selbstangaben, Jahre des Fensters nicht genannt.
- 2026-10-13
Zweites Jahr als Gartner Challenger (laut Propensity)
Analystenplatzierung laut Firmenmeldung, Bericht nicht gelesen.
- 2026-11-12
Preisseite: Essential 2'000, Strategic 3'000, Unlimited 4'000 Dollar
Datum ist der Cache der Preisseite. Wayback zeigt am 13.11.2025 noch Essential 1'000 und Strategic 2'000, am 26.10.2026 schon 2'000, 3'000 und 4'000. Die Erhöhung liegt zwischen 13.11.2025 und 26.10.2026.
Observed GTM signals
Observations from stored data, not an analysis. They show where the GTM strategy starts; the full analysis explains why.
- Team trend
- Growing: +38% in 12 months, +90% in 24 months.
- Team today: 40 (2026-01-01)
- Competitive set
- Demandbase, 6sense, Terminus
Similar companies
Similar means: same category, then the same pricing model, similar team size and region (rule similar/1). Empty groups are not shown.
Similar companies with observed team growth
More similar companies: team size flat or shrinking
FAQ
- Why is Propensity growing?
- Propensity grew on LinkedIn from 29 employees on 2025-01-01 to 40 on 2026-01-01 (+38%), and LinkedIn counts 53 on 2026-11-15, a separate measurement. Documented are a free entry with visible prices, higher price tiers (Essential from 1,000 (09.2025) to 2,000 dollars per month (pricing page 11.2026)) and the Gartner Challenger placement. The CEO names a human validation step before sales as a driver, which is his statement. Revenue, customer count and funding are open.
- Which GTM motion does Propensity use?
- The strongest observed GTM motions at Propensity are: Product-led sales.
- How fast is Propensity growing?
- Propensity's headcount grew from 29 to 40 employees (+38% over 12 months, based on LinkedIn data).
Put it to work
The method behind these patterns is in the playbook of The Science of GTM. If you want to build a GTM engine on this model, Pedalix implements it with you.